LYBQT63LyondellBasell Industries N.V.·NYSE
68.64+5.00%
News
Up 5.0% — LyondellBasell reports third quarter 2026 earnings (globenewswire.com).
Medium confidence
TA
Loading chart...
Screen all →
Snapshot
IndexS&P 500P/E41.35EPS (ttm)1.66Insider Own13.17%Shs Outstand323.04MPerf Week3.30%
Market Cap22.17BForward P/E10.99EPS next Y6.25Insider Trans-0.02%Shs Float257.58MPerf Month18.80%
Enterprise Value33.76BPEG—EPS next Q—Short Float4.48%Perf Quarter13.23%
Income1.32BP/S0.94EPS this Y332.38%Short Ratio2.98Perf Half Y-8.47%
Sales23.46BP/B2.08EPS next Y-32.03%ROA0.00%Short Interest11.53MPerf YTD58.52%
Book/sh33.06P/C8.43EPS next 5Y-16.15%ROE12.54%52W High83.94 -18.23%Perf Year46.95%
Cash/sh8.14P/FCF4.32EPS past 3/5Y—ROIC-36.39%52W Low41.58 65.08%Perf 3Y-23.08%
Dividend Est.2.76 (4.02%)EV/EBITDA10.16Sales past 3/5Y-15.77% 1.67%Gross Margin-16.21%Volatility3.58% 2.89%Perf 5Y-29.52%
Dividend TTM3.44 (5.01%)EV/Sales1.44EPS Y/Y TTM—Oper. Margin11.97%ATR (14)2.03Perf 10Y-15.84%
Dividend Ex-DateAug 24, 2026Quick Ratio—Sales Y/Y TTM-27.93%Profit Margin5.62%RSI (14)68.07Recom2.63
Dividend Gr. 3/5Y-18.04% 5.35%Current Ratio—EPS Q/Q151.49%SMA208.70%Beta0.34Target Price68.56
Payout32.25%Debt/Eq1.33Sales Q/Q-100.00%SMA509.40%Rel Volume1.28Prev Close65.37
Employees18,970LT Debt/Eq1.17EarningsJan 29SMA2007.52%Avg Volume3.63MPrice68.64
IPO DateApr 28, 2010Option/ShortYes / YesEPS/Sales Surpr.-1.27% -4.23%Net Debt/EBITDA3.49Volume4,641,310Change5.00%
Analyst Ratings
DateActionAnalystRatingTarget
Oct-13-26ReiteratedRBC CapitalOutperform$72 → $68
Oct-12-26InitiatedBarclaysEqual Weight$100 → $66
Sep-30-26DowngradeCitigroupBuy → Neutral
Sep-25-26ReiteratedUBSNeutral$64 → $62
Aug-05-26ReiteratedRBC CapitalOutperform$80 → $72
Aug-04-26ReiteratedUBSNeutral$73 → $64
Aug-03-26ReiteratedRBC CapitalOutperform$91 → $80
Aug-03-26UpgradeJP MorganNeutral → Overweight
Aug-03-26ReiteratedMizuhoNeutral$62 → $66
Aug-03-26ReiteratedBMO CapitalMarket Perform$64 → $68
Latest News· Times ET
Oct-30-26
Oct-27-26
Oct-26-26
Oct-24-26
Oct-23-26
Oct-22-26
Oct-19-26
Oct-16-26
Company

LyondellBasell Industries N.V., established in 2009 and based in Houston, Texas, operates as a prominent global chemical manufacturer with a significant international footprint, including the United States, Germany, Mexico, Italy, Poland, France, Japan, China, and the Netherlands. The company's diverse operations are organized into six distinct segments. Its core business involves the production and marketing of olefins and various polyolefins, such as high, low, and linear low-density polyethylene, along with polypropylene homopolymers and copolymers, for markets spanning the Americas, Europe, and Asia. LyondellBasell also focuses on intermediate chemicals and derivatives, offering products like propylene oxide, oxyfuels, styrene monomers, acetyls, and ethylene-based compounds. Furthermore, the company develops and sells advanced polymer solutions, including polypropylene compounds, engineered plastics, masterbatches, engineered composites, colors, and powders. Its activities extend to refining crude oil into gasoline and distillates, as well as the development and licensing of chemical and polyolefin process technologies, alongside the manufacturing and sale of polyolefin catalysts.

Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
12/31/2018
Total Revenue23,46530,15340,30241,107—————
Cost of Goods Sold Incl. D&A27,26927,43835,73835,849—————
Gross Profit-3,8042,7154,5645,258—————
Selling, General and Administrative Excl. Other1,6571,7021,6631,557—————
Research and Development140138135130—————
Other Operating Expense891,202949518—————
Operating Income2,809-3271,8173,053—————
Interest Expense224507481477—————
Unusual Expense
—————————
Non-Operating Income (Expense)-82612226751—————
Net Income Before Taxes1,759-7121,6032,627—————
Income Taxes41479240501—————
Consolidated Net Income1,318-7431,3602,114—————
Net Income From Continuing Operations571-7911,3632,126—————
Net Income1,318-7431,3602,114—————
EPS (Recurring)1.65-2.354.166.48—————
EPS (Basic, Before Extraordinaries)1.65-2.354.166.48—————
EPS (Diluted)1.66-2.354.156.46—————
EBITDA3,3221,1853,6064,638—————
Other After Tax Adjustments
—————————
Stock Option Compensation Expense
—————————
Price To Earnings Ratio41.35—17.9014.72—————
Price To Sales Ratio—0.460.600.75—————
Gross Margin-16.219.0011.3212.79—————
Operating Margin11.97-1.084.517.43—————
Net Margin5.62-2.463.375.14—————
Shares Outstanding0322325325—————
Market Capitalization—13,94324,13830,901—————
Operating Lease Expense
—————————
Unlock full historical data
See years of past statements with Premium.
Unlock with Premium
Insider Trading Volume
$88.39$75.36$62.33$49.30$36.27● Close Price0.00M6.56M13.13M19.69M26.26MUSD Trades VolumeNovDec2026FebMarAprMayJunJulAugSepOctNov
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
Kaplan Jeffrey AEVP, Chief PC, Leg & Corp OfcMay 13 '26Sale74.1610,000741,57396,674May 15
AI INVESTMENTS HOLDINGS LLC10% OwnerMar 09 '26Sale68.13385,39026,256,664765,154Mar 11
Foley Kimberly AEVP, Global O&P and RefiningNov 12 '25Buy43.565,661246,62167,688Nov 12
Vanacker Peter Z. E.Chief Executive OfficerAug 15 '25Sale53.5720,0001,071,422160,351Aug 15
ACCESS INDUSTRIES, LLC10% OwnerJun 13 '25Buy79.99302,40030Jun 13
Hanley Michael SeanDirectorMay 05 '25Buy57.013,500199,53519,528May 06
Hanley Michael SeanDirectorMar 12 '25Buy72.053,750270,19716,028Mar 13
Buchanan Robin W.T.DirectorMar 18 '24Sale99.9118418,174Jan 24
Buchanan Robin W.T.DirectorDec 13 '24Buy76.065,000380,30018,175Dec 16
Friedrichs Dale DEVP, Ops Excellence, HSEAug 20 '24Sale96.784,970480,99734,220Aug 22
QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.